CAS 104291-17-0

Formel: C11H13ClN4O3

InChl: InChI=1S/C11H13ClN4O3/c12-9-5-1-2-16(10(5)15-11(13)14-9)8-3-6(18)7(4-17)19-8/h1-2,6-8,17-18H,3-4H2,(H2,13,14,15)/t6-,7+,8-/m0/s1

InChI Key: BZICGWWJWKJNCN-RNJXMRFFSA-N

SMILES: C1[C@@H]([C@H](O[C@@H]1N2C=CC3=C2N=C(N=C3Cl)N)CO)O

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

CAS: 104291-17-0

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

Formel: C₁₁H₁₃ClN₄O₃

Reinheit: >95%

Molekulargewicht: 284.7

Ref: 54-OR1064080

7-Deaza-4-Cl-2’-dG

CAS: 104291-17-0

Formel: C₁₁H₁₃ClN₄O₃

Reinheit: %

Farbe und Form: Solid

Molekulargewicht: 284.6989

Ref: IN-DA008SL4

7-Deaza-4-Cl-2'-deoxyguanosine

CAS: 104291-17-0

7-Deaza-4-Cl-2'-deoxyguanosine is a novel antiviral drug that has been synthesized in the laboratory. It is an analogue of deoxyguanosine, a nucleoside that is found in DNA and RNA. 7-Deaza-4-Cl-2'-deoxyguanosine has anti cancer properties because it inhibits the synthesis of DNA by inhibiting the activity of ribonucleoside reductase, an enzyme that converts ribonucleosides to deoxyribonucleosides. This drug has been shown to have potent anticancer activity against human lung cancer cells and mouse leukemia cells.

Formel: C₁₁H₁₃ClN₄O₃

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 284.7 g/mol

Ref: 3D-ND57492

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

CAS: 104291-17-0

Reinheit: 95+%

Molekulargewicht: 284.7000122

Ref: 10-F869453

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

CAS: 104291-17-0

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

Formel: C₁₁H₁₃ClN₄O₃

Reinheit: 95+%

Molekulargewicht: 284.7

Ref: IN-DG291285